New Drugs of Abuse

作者: Megan A. Rech , Elisabeth Donahey , Jacqueline M. Cappiello Dziedzic , Laura Oh , Elizabeth Greenhalgh

DOI: 10.1002/PHAR.1522

关键词:

摘要: Drug abuse is a common problem and growing concern in the United States, over past decade, novel or atypical drugs have emerged become increasingly popular. Recognition treatment of new pose many challenges for health care providers due to lack quantitative reporting routine surveillance, difficulty detection blood urine analyses. Furthermore, street manufacturers are able rapidly adapt develop synthetic isolates older as soon law enforcement agencies render them illegal. In this article, we describe clinical adverse effects purported pharmacology several classes including cannabinoids, cathinones, salvia, desomorphine, kratom. Because these substances can severe life-threatening effects, knowledge general toxicology key recognizing acute intoxication overdose; however, typical toxidromes (e.g., cholinergic, sympathomimetic, opioid, etc.) not precipitated by agents. Medical management patients who overdose on largely consists supportive care, although naloxone may be used an antidote desomorphine overdose. Symptoms aggression psychosis treated with sedation (benzodiazepines, propofol) antipsychotics (haloperidol agents such quetiapine ziprasidone). Other facets consider include withdrawal addiction, nutrition support, potential transmission infectious diseases.

参考文章(60)
Olav J. Braenden, H. Halbach, Nathan B. Eddy, Synthetic substances with morphine-like effect: Clinical experience: potency, side-effects, addiction liability* Bulletin of The World Health Organization. ,vol. 17, pp. 569- 863 ,(1957)
Karen Banasiak, Here Today, Gone Tomorrow Food Technology. ,vol. 59, pp. 40- 43 ,(2005)
Duccio Papanti, Fabrizio Schifano, Giulia Botteon, Francesca Bertossi, Jason Mannix, Daniela Vidoni, Matteo Impagnatiello, Elisabetta Pascolo-Fabrici, Tommaso Bonavigo, “Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case report Human Psychopharmacology-clinical and Experimental. ,vol. 28, pp. 379- 389 ,(2013) , 10.1002/HUP.2312
Mathias B. Forrester, Kratom Exposures Reported to Texas Poison Centers Journal of Addictive Diseases. ,vol. 32, pp. 396- 400 ,(2013) , 10.1080/10550887.2013.854153
PETER PRZEKOP, TIMOTHY LEE, Persistent psychosis associated with salvia divinorum use. American Journal of Psychiatry. ,vol. 166, pp. 832- 832 ,(2009) , 10.1176/APPI.AJP.2009.08121759
Lisa K. Brents, Anna Gallus-Zawada, Anna Radominska-Pandya, Tamara Vasiljevik, Thomas E. Prisinzano, William E. Fantegrossi, Jeffery H. Moran, Paul L. Prather, Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity Biochemical Pharmacology. ,vol. 83, pp. 952- 961 ,(2012) , 10.1016/J.BCP.2012.01.004
M. E. Sutter, J. Chenoweth, T. E. Albertson, Alternative Drugs of Abuse Clinical Reviews in Allergy & Immunology. ,vol. 46, pp. 3- 18 ,(2014) , 10.1007/S12016-013-8370-2
Adedotun Adebamiro, Mark A. Perazella, Recurrent Acute Kidney Injury Following Bath Salts Intoxication American Journal of Kidney Diseases. ,vol. 59, pp. 273- 275 ,(2012) , 10.1053/J.AJKD.2011.10.012
Anne-Christin Stolt, Helmut Schröder, Hartmud Neurath, Gisela Grecksch, Volker Höllt, Markus R. Meyer, Hans H. Maurer, Nancy Ziebolz, Ursula Havemann-Reinecke, Axel Becker, Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract. Psychopharmacology. ,vol. 231, pp. 13- 25 ,(2014) , 10.1007/S00213-013-3201-Y